A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FIB-4 / fibrosis-4 score

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FIB-4  (>> Co-occurring Abbreviation)
Long Form:   fibrosis-4 score
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Novel Prediction Model for Significant Liver Fibrosis in Patients with Chronic Hepatitis B. APRI, AUROC, CHB, LN, PLT
2020 Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. APRI, CAD, GPR, LF, NFS
2020 Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score. APRI, baPWV, CI, CIMT, NAFLD, NFS, SD
2020 Clinically Significant Fibrosis Is Associated With Longitudinal Increases in Fibrosis-4 and Nonalcoholic Fatty Liver Disease Fibrosis Scores. CSF, NAFLD
2020 Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years. COVID-19, SARS-CoV-2
2020 Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B. APRI, AUROC, CHB, NITs, PCT, ROC
2020 Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis. AIH, APRI, AUROC, CI, IQR, RPR
2020 Shorter leucocyte telomere length as a potential biomarker for nonalcoholic fatty liver disease-related advanced fibrosis in T2DM patients. ALT, LTL, NAFLD, NFS, T2DM
2020 The association of low-grade albuminuria with incident nonalcoholic fatty liver disease and non-invasive markers of liver fibrosis by glycemic status. FLI, HFS, NFS
10  2019 Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B. APRI, AUROC, CHB, GPR, NPV, PLR, PPV, TE
11  2019 Association between nonalcoholic fatty liver disease with advanced fibrosis and stroke. NAFLD-fibrosis, NFS
12  2019 Association between urinary thiodiglycolic acid level and hepatic function or fibrosis index in school-aged children living near a petrochemical complex. APRI, AST, OR, TDGA, VCM
13  2019 Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients. APRI, AST, BL, DAAs, EOT, FU, HCV, MFAP4
14  2019 microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. AST, CHC, HCV, LSM, ROC
15  2019 Non-Alcoholic Fatty Liver Disease and Its Association with Depression in Korean General Population. CES-D, CI, FLI, NAFLD, ORs
16  2019 Noninvasive inflammatory markers for assessing liver fibrosis stage in autoimmune hepatitis patients. AAR, AIH, APRI, IGPR, LMR, LNR, LPR
17  2019 Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore. APRI, AST, NPV, PPV, TE
18  2019 Prediction and Staging of Hepatic Fibrosis in Children with Hepatitis C Virus: A Machine Learning Approach. APRI, AUC, CHC, RF
19  2019 The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B. APRI, AUROCs, CHB, eLIFT, GPR, RPR
20  2019 The preoperative fibrosis score 4 predicts posthepatectomy liver failure in patients with hepatocellular carcinoma. HCC, ROC
21  2018 A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care. BMI, ELF, LSMs, NFS
22  2018 Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis. AAR, API, APRI, AST, CBC, FibroQ, SF
23  2018 Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort. ARFI, DAAs, IQR, LSM, LT, SVR, SVR24, TE
24  2018 Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods. APRI, ARFI, HCV, LSM
25  2017 A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B. AAR, ALP, AST, AUROCs, CHB, GGT, PLT, RDW-SD, RPR
26  2017 Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis. APRI, LT, TE
27  2016 Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome. AGC, API, APRI, CI, CRC, PSR, SOS, SVI
28  2016 Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients. APRI, CT, HCV, PV, ROC
29  2016 Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients. AST, CHB, GPRI
30  2016 High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262). APRI, ART
31  2016 Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience. AIH, ALT, ALV, APRI, AST, NAFLD, TE
32  2016 Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis. AIH, APRI, AST, AUROC, PC/SD
33  2016 The FIB-4 score predicts postoperative short-term outcomes of hepatocellular carcinoma fulfilling the milan criteria. HCC, HR, ROC
34  2016 The Relationship between Serum Bilirubin and Elevated Fibrotic Indices among HBV Carriers: A Cross-Sectional Study of a Chinese Population. APRI, DBIL, HBsAg, HBV, IBIL, TBIL
35  2015 Non-invasive serum fibrosis markers: A study in chronic hepatitis. APRI, AST, ROC
36  2015 Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients. aHR, APRI, CI, LT, NAFLD